LL37

LL-37 7 mg: Research Peptide
Only for use in laboratory research. Not for ingestion by humans.
The C-terminal domain of human cathelicidin (hCAP-18) is the source of LL-37, a 37-amino-acid cationic antimicrobial peptide. Preclinical research on innate immunity, antibacterial activity, and inflammatory modulation uses this 7 mg lyophilized formulation, which delivers high purity (HPLC validated).
Important applications for research:
Studies on antimicrobial and antibacterial activity
Research on host protection and innate immune response
Models of tissue repair and wound healing Immunomodulatory and anti-inflammatory properties
Studies on antiviral and antifungal activities
Studies on gut barrier function and microbiome interactions
Details of the product:
Form: Powdered lyophilized
Purity: at least 99%
Each vial contains 6.97 mg of net peptide.
Weight in molecules: about 4493 g/mol
Look: White powder that has been lyophilized
Storage: -20°C (before to reconstitution)
Solubility: Bacteriostatic or sterile water
Managing:
Use sterile, bacteriostatic water to reconstitute. Do not vortex; instead, gently swirl. To prevent freeze-thaw cycles, use an aliquot.
Crucial:
This product is only provided for animal and in vitro research. Not for human, medical, or diagnostic purposes. must be managed by trained individuals wearing the proper PPE.